Screener
Innospec IOSP Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Innospec in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Innospec’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 9:34 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-213510
| (in millions, except share and per share data) | March 31,2026 | December 31,2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $289.1 | $292.5 |
| Trade and other accounts receivable (less allowances of $14.2 million and $11.8 million respectively) | 354.2 | 342.3 |
| Inventories (less allowances of $39.4 million and $40.4 million respectively): | ||
| Finished goods | 225.6 | 226.3 |
| Raw materials | 95.9 | 103.0 |
| Total inventories | 321.5 | 329.3 |
Item 1 Condensed Consolidated Financial Statements
FAQ
- What is Innospec's cash & equivalents?
- Innospec (IOSP) reported cash & equivalents of $289.1M in Q1 2026.
- How has Innospec's cash & equivalents changed year-over-year?
- Innospec's cash & equivalents decreased by 3.6% year-over-year, from $299.8M to $289.1M.
- What is the long-term trend for Innospec's cash & equivalents?
- Over 5 years (2020 to 2025), Innospec's cash & equivalents has grown at a 22.7% compound annual growth rate (CAGR), from $105.3M to $292.5M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Innospec's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude